Menu
Not yet recruiting NCT07428031

French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy

— Observational Cardiomyopathy Hypertrophic Cardiomyopathies

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Cardiomyopathy, Hypertrophic Cardiomyopathies. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Retrospective French Registry of Cardiovascular Magnetic Resonance Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy

Overview

This study aims to create a registry of patients with hypertrophic cardiomyopathy, a condition characterized by excessive thickening of the heart muscle. This disease can sometimes lead to serious complications. Currently, the prognosis of these patients is mainly determined by clinical and echocardiographic parameters. Detection of myocardial fibrosis using cardiac MRI enables better risk stratification for these patients.

Primary outcome measures

  • To build a score using the "LGE granularity" concept for all-cause mortality prediction in HCM patients. [Time frame: From Baseline to 5 years]

Eligibility criteria

Inclusion criteria

  • Age ≥ 18 years
  • Ability to provide informed consent
  • HCM diagnosis referred for CMR assessment.

Exclusion criteria

  • Patients unable to provide informed consent,
  • Patients with a history of ischemic cardiomyopathy or myocarditis.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07428031 · APHP251019

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗